Shareo.

CU6 · bearish

Called by Equity Mates Investing Podcast on 2026-09-03 · horizon: long term

“Clarity Pharmaceuticals, really good data, but, you know, you're looking at things again one, two, three years out...Australian biotech where they're generally capital constrained, and so they do small trials.”

No settled horizons yet — outcomes appear at 30/90/365 days.